These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37321037)

  • 1. Lipocalin-2 regulates the expression of interferon-stimulated genes and the susceptibility of prostate cancer cells to oncolytic virus infection.
    Barer L; Schröder SK; Weiskirchen R; Bacharach E; Ehrlich M
    Eur J Cell Biol; 2023 Jun; 102(2):151328. PubMed ID: 37321037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 and Interferon-α Signaling
    Danziger O; Pupko T; Bacharach E; Ehrlich M
    Front Immunol; 2018; 9():94. PubMed ID: 29441069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9-mediated knockout of Lcn2 effectively enhanced CDDP-induced apoptosis and reduced cell migration capacity of PC3 cells.
    Rahimi S; Roushandeh AM; Ebrahimi A; Samadani AA; Kuwahara Y; Roudkenar MH
    Life Sci; 2019 Aug; 231():116586. PubMed ID: 31220528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined genetic and epigenetic interferences with interferon signaling expose prostate cancer cells to viral infection.
    Danziger O; Shai B; Sabo Y; Bacharach E; Ehrlich M
    Oncotarget; 2016 Aug; 7(32):52115-52134. PubMed ID: 27366948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive low expression of antiviral effectors sensitizes melanoma cells to a novel oncolytic virus.
    Dellac S; Ben-Dov H; Raanan A; Saleem H; Zamostiano R; Semyatich R; Lavi S; Witz IP; Bacharach E; Ehrlich M
    Int J Cancer; 2021 May; 148(9):2321-2334. PubMed ID: 33197301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipocalin-2 (LCN2) Deficiency Leads to Cellular Changes in Highly Metastatic Human Prostate Cancer Cell Line PC-3.
    Schröder SK; Pinoé-Schmidt M; Weiskirchen R
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense.
    Echchgadda I; Chang TH; Sabbah A; Bakri I; Ikeno Y; Hubbard GB; Chatterjee B; Bose S
    BMC Cancer; 2011 Jan; 11():43. PubMed ID: 21276246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-α controls Lipocalin-2 expression in PC-3 prostate cancer cells.
    Schröder SK; Asimakopoulou A; Tillmann S; Koschmieder S; Weiskirchen R
    Cytokine; 2020 Nov; 135():155214. PubMed ID: 32712458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the IFNγ-JAK-STAT Pathway Causing Resistance to Immune Checkpoint Inhibitors in Melanoma Increase Sensitivity to Oncolytic Virus Treatment.
    Nguyen TT; Ramsay L; Ahanfeshar-Adams M; Lajoie M; Schadendorf D; Alain T; Watson IR
    Clin Cancer Res; 2021 Jun; 27(12):3432-3442. PubMed ID: 33593882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
    Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
    Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial Peptide LCN2 Inhibited Uropathogenic
    Chen PC; Ho CH; Fan CK; Liu SP; Cheng PC
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orf virus inhibits interferon stimulated gene expression and modulates the JAK/STAT signalling pathway.
    Harvey R; McCaughan C; Wise LM; Mercer AA; Fleming SB
    Virus Res; 2015 Oct; 208():180-8. PubMed ID: 26113305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 27, like interferons, activates JAK-STAT signaling and promotes pro-inflammatory and antiviral states that interfere with dengue and chikungunya viruses replication in human macrophages.
    Valdés-López JF; Hernández-Sarmiento LJ; Tamayo-Molina YS; Velilla-Hernández PA; Rodenhuis-Zybert IA; Urcuqui-Inchima S
    Front Immunol; 2024; 15():1385473. PubMed ID: 38720890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling.
    Moerdyk-Schauwecker M; Shah NR; Murphy AM; Hastie E; Mukherjee P; Grdzelishvili VZ
    Virology; 2013 Feb; 436(1):221-34. PubMed ID: 23246628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the IFN-α JAK/STAT Pathway by MERS-CoV and SARS-CoV-1 Proteins in Human Epithelial Cells.
    Zhang Y; Gargan S; Roche FM; Frieman M; Stevenson NJ
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Promotes the Degradation of Components of the Type 1 IFN JAK/STAT Pathway and Blocks Anti-viral ISG Induction.
    Gargan S; Ahmed S; Mahony R; Bannan C; Napoletano S; O'Farrelly C; Borrow P; Bergin C; Stevenson NJ
    EBioMedicine; 2018 Apr; 30():203-216. PubMed ID: 29580840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naturally Occurring and Engineered Alphaviruses Sensitive to Double-Stranded-RNA-Activated Protein Kinase Show Restricted Translation in Mammalian Cells, Increased Sensitivity to Interferon, and Marked Oncotropism.
    Toribio R; Díaz-López I; Berlanga JJ; Molina-Jiménez F; Majano P; Ventoso I
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31723025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-stimulated genes: a complex web of host defenses.
    Schneider WM; Chevillotte MD; Rice CM
    Annu Rev Immunol; 2014; 32():513-45. PubMed ID: 24555472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDA5 against enteric viruses through induction of interferon-like response partially via the JAK-STAT cascade.
    Li Y; Yu P; Qu C; Li P; Li Y; Ma Z; Wang W; de Man RA; Peppelenbosch MP; Pan Q
    Antiviral Res; 2020 Apr; 176():104743. PubMed ID: 32057771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity.
    Ding G; Wang J; Feng C; Jiang H; Xu J; Ding Q
    Oncotarget; 2016 Sep; 7(39):64309-64317. PubMed ID: 27602760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.